Position in SIGA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,039,684
+$52,625 QoQ
Shares Held
560,353
+50.9% QoQ
Ownership
0.780%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#16
of 161 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Uniplan Investment Counsel, Inc. holds $6,293,960 across 3 Drug Manufacturers - Specialty & Generic names. SIGA ranks #2 (32.4% of the industry book) .
All Filings in SIGA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,039,684 | 560,353 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,987,059 | 371,413 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,418,930 | 395,897 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,628,148 | 396,519 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,009,312 | 461,551 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,764,994 | 504,561 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,010,943 | 500,989 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,418,125 | 506,389 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,633,396 | 346,956 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,910,872 | 573,700 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,201,391 | 571,677 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,221,044 | 423,056 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,086,831 | 413,234 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,457,211 | 253,428 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $682,765 | 92,767 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $951,503 | 92,379 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,197,499 | 103,411 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||